The purpose of the study is to evaluate the outcome of treatment switch defined as an improvement in CGI-CB scale (Clinical Global Impression - Clinical Benefit).
Study Type
OBSERVATIONAL
Enrollment
574
CGI-CB scale score of subjects achieving a score of < 4.
Time frame: At Week 18 - once
Change in PANSS scale
Time frame: Baseline (Day 0) to the end of study treatment (week 6, week 12, week 18) or the premature study withdrawal of the subject - up to 4 times in 18 weeks
Change in BARS scale
Time frame: Baseline (Day 0) to the end of study treatment (week 6, week 12, week 18) or the premature study withdrawal of the subject - up to 4 times in 18 weeks
Changes in CGI-S and CGI-I scales
Time frame: Baseline (Day 0) to the end of study treatment (week 6, week 12, week 18) or the premature study withdrawal of the subject - up to 4 times in 18 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Pátrai, Achaias, Greece
Research Site
Nafplion, Argolidas, Greece
Research Site
Tripoli, Arkadias, Greece
Research Site
Athens, Attica, Greece
Research Site
Dafni, Attica, Greece
Research Site
Drapetsona, Attica, Greece
Research Site
Exarcheia, Attica, Greece
Research Site
Glifada, Attica, Greece
Research Site
Ilioúpoli, Attica, Greece
Research Site
Ilissia, Attica, Greece
...and 33 more locations